(480) 923-0802
Join Our Panel
Consulting
Insights
Podcast
DVI
About
Contact Us
Posts Tagged ‘fda
All Categories
Our Take Newsletter
Downloadable Articles
By the Numbers
September 25, 2023
Our Take: CommonSpirit launches PHSO to ‘help providers succeed in value-based care’
Read More
September 18, 2023
Our Take: J&J to rename Janssen Pharmaceuticals as part of its branding update
Read More
September 11, 2023
Our Take: Froedtert Health and ThedaCare move closer to combining, two other mergers are completed
Read More
August 28, 2023
Our Take: CVS launches new biosimilar subsidiary Cordavis
Read More
August 21, 2023
Our Take: Optum-Amedisys deal delayed after DOJ requests more information
Read More
August 14, 2023
Our Take: Novo Nordisk eyes potential cardiovascular indication for semaglutide, adds CB1 blocker to weight-loss pipeline
Read More
August 07, 2023
Our Take: CVS Health to lay off 5,000 employees as part of restructuring plan, lowers future earnings outlook
Read More
July 31, 2023
Our Take: Sanford ends proposal to merge with Fairview based on lack of support by ‘certain stakeholders’
Read More
July 24, 2023
Our Take: FEATURE: Tracking Teladoc’s ascent to, and continued presence at, the top of the telehealth industry
Read More
July 17, 2023
Our Take: Home health industry group sues federal government over rate cuts
Read More
July 10, 2023
Our Take: Amedisys chooses Optum over Option Care Health in cash deal worth more than $3 billion
Read More
June 26, 2023
Our Take: Embracing the use of ChatGPT with enthusiasm and caution, preferably in equal measure
Read More
June 19, 2023
Our Take: CMS releases list of 43 Part B drugs flagged for quarterly rebates in IRA program
Read More
June 12, 2023
Our Take: Optum makes an unsolicited $3.3 billion bid for Amedisys, potentially starting a bidding war with Option Care Health
Read More
Posts navigation
1
2
…
12
Next
Sign up for Our Take
the weekly strategic brief for Health Care Executives
Please leave this field empty
Business Email
*
Check your inbox or spam folder to confirm your subscription.
share
Contact Darwin Research Group and we will get right back to you.
Please leave this field empty.
Consulting
Insights
Podcast
DVI
About
Contact Us